Rein Therapeutics, Inc. (RNTX) KPIs and segments
RNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.36−0.04 (-10.90%)
Close on Nov 17, 2026Market cap $30.75MP/E –Yield 0.00%
KPIs & segments
Operating metrics and segments that drive Rein Therapeutics's business
Coming soon
This tab will track the numbers specific to Rein Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?